Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells von Zhou, Zhiwei, He, Huabin, Wang, Kun, Shi, Xuyan, Wang, Yupeng, Su, Ya, Wang, Yao, Li, Da, Liu, Wang, Zhang, Yongliang, Shen, Lianjun, Han, Weidong, Shen, Lin, Ding, Jingjin, Shao, Feng

Volltext

Phase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumors von Wang, Zhenguang, Li, Na, Feng, Kaichao, Chen, Meixia, Zhang, Yan, Liu, Yang, Yang, Qingming, Nie, Jing, Tang, Na, Zhang, Xingying, Cheng, Chen, Shen, Lianjun, He, Jiaping, Ye, Xun, Cao, Wei, Wang, Haoyi, Han, Weidong

Volltext

Cross-presentation: underlying mechanisms and role in immune surveillance von Rock, Kenneth L., Shen, Lianjun

Volltext

Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study von Yang, Junfang, He, Jiaping, Zhang, Xian, Li, Jingjing, Wang, Zhenguang, Zhang, Yongliang, Qiu, Liyuan, Wu, Qionglu, Sun, Zhe, Ye, Xun, Yin, Wenjie, Cao, Wei, Shen, Lianjun, Sersch, Martina, Lu, Peihua

Volltext

Proteases in MHC Class I Presentation and Cross-Presentation von Rock, Kenneth L, Farfan-Arribas, Diego J, Shen, Lianjun

Volltext

Novel CD19 chimeric antigen receptor T cells manufactured next-day for acute lymphoblastic leukemia von Zhang, Cheng, He, Jiaping, Liu, Li, Wang, Jishi, Wang, Sanbin, Liu, Ligen, Ge, Jian, Gao, Lei, Gao, Li, Kong, Peiyan, Liu, Yao, Liu, Jia, Han, Yu, Zhang, Yongliang, Sun, Zhe, Ye, Xun, Yin, Wenjie, Sersch, Martina, Shen, Lianjun, Cao, Wei William, Zhang, Xi

Volltext

Cellular Protein Is the Source of Cross-Priming Antigen in vivo von Shen, Lianjun, Rock, Kenneth L., Benacerraf, Baruj

Volltext

248 SMART CAR-T cells resist tumor immunosuppressive microenvironment with enhanced efficacy against solid tumors von Dong, Qi, Yin, Wenjie, Yin, Manli, Wang, Tao, Wu, Di, Wang, Xinxin, Cao, William, Shen, Lianjun

Volltext

Protein S gene mutation c.946C > T (p.R316C) contributed to ischemic stroke in a man with von Willebrand disease type 3 caused by two novel VWF gene mutations, c.2328delT (p.A778Lf... von Hua, Baolai, Yan, Xiaobo, He, Bin, Shen, Lianjun, Poon, Man‐Chiu

Volltext

P369: DONOR‐DERIVED ANTI‐CD19 CHIMERIC ANTIGEN RECEPTOR T CELLS FOR B‐CELL ACUTE LYMPHOBLASTIC LEUKEMIA: A PHASE 1 TRIAL von Luo, Yi, Gao, Lei, Liu, Jia, Yang, Luxin, Wang, Lu, Lai, Xiaoyu, Gao, Shichun, Liu, Lizhen, Zhao, Lu, Ye, Yishan, Wang, Manning, Liao, Shengyu, Shen, Lianjun, William Cao, Wei, Wang, Dongrui, LI, Wenling, Zhang, XI, Huang, He

Volltext

110 IL-2 variant improves CAR-T functionality and efficacy against solid tumors von Dong, Qi, Yin, Wenjie, Jiang, Pengfei, Yin, Manli, Wang, Tao, Wang, Ping, Wang, Xinxin, Cao, William Wei, Shen, Lianjun

Volltext

TLR4 is a negative regulator in noninfectious lung inflammation von Zhao, Hang, Leu, Shaw-Wei, Shi, Liyun, Dedaj, Rejmon, Zhao, Gaofeng, Garg, Hari G, Shen, Lianjun, Lien, Egil, Fitzgerald, Katherine A, Shiedlin, Aviva, Shen, Huahao, Quinn, Deborah A, Hales, Charles A

Volltext

P869: UPDATED RESULTS OF A PHASE I, OPEN‐LABEL STUDY OF BCMA/CD19 DUAL‐TARGETING FASTCAR‐T GC012F FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) von Du, Juan, Fu, Weijun, Jiang, Hua, Dong, Baoxia, Gao, LI, Liu, LI, Ge, Jian, He, Aili, LI, Lu, Lu, Jing, Chen, Xiequn, Liu, Jia, Zhang, Qi, He, Jiaping, Weng, Lihong, Zhang, Hua, Shen, Lianjun, Cao, Wei, LI, Wenling

Volltext

S234: UPDATED CLINICAL RESULTS OF FIRST‐IN‐HUMAN STUDY OF CD19/BCMA DUAL‐TARGETING FAST CAR‐T GC012F FOR PATIENTS WITH RELAPSED/REFRACTORY B‐CELL NON‐HODGKIN’S LYMPHOMA... von Chen, Xinfeng, Ping, Yu, LI, Ling, Zhang, Lei, Zhang, Xudong, Huang, Jianmin, Liu, Jia, LI, Gui, He, Jiaping, Zhang, Hua, Zhao, Wei, Weng, Lihong, Yin, Wenjie, Shen, Lianjun, Cao, Wei William, LI, Wenling, Zhang, Mingzhi, Zhang, Yi

Volltext

Assessment of roles for calreticulin in the cross-presentation of soluble and bead-associated antigens von Del Cid, Natasha, Shen, Lianjun, Belleisle, Janice, Raghavan, Malini

Volltext

Eradication of T-ALL Cells by CD7-targeted Universal CAR-T Cells and Initial Test of Ruxolitinib-based CRS Management von Li, Shiqi, Wang, Xinxin, Yuan, Zhongtao, Liu, Lin, Luo, Le, Li, Yu, Wu, Kun, Liu, Jia, Yang, Chunhui, Li, Zhimin, Wang, Duanpeng, Shen, Lianjun, Ye, Xun, He, Jiaping, Han, Cong, Wang, Youcheng, Zhang, Dingsong, Dong, Yancheng, Fang, Lihua, Chen, Yingnian, Sersch, Martina, Cao, Wei William, Wang, Sanbin

Volltext

Exploiting T cell signaling to optimize engineered T cell therapies von Wang, Haopeng, Song, Xianming, Shen, Lianjun, Wang, Xinxin, Xu, Chenqi

Volltext

Preclinical Results of an Allogeneic, Universal CD19/CD7-Targeting CAR-T Cell Therapy (GC502) for B Cell Malignancies von Ge, Jianning, Yang, Chunhui, Sun, Jing, Chen, Jiao, Qiu, Shuyi, Yin, Wenjie, Shen, Lianjun, Sersch, Martina, Cao, Wei, Wang, Xinxin

Volltext

Prevalence and genotype distribution of high‐risk human papillomavirus infection among women with cervical cytological abnormalities in Chongqing, China, 2014–2020 von Luo, Qinli, Lang, Lin, Han, Na, Liang, Ling, Shen, Lianjun, Zhang, Haiyan

Volltext

RNASEH1-AS1 induced by H3K27ac stabilizes ANXA2 mRNA to promote the progression of colorectal cancer through recruiting BUD13 von Zhuang, Shengwei, Lu, Weihong, Shen, Lianjun, Huang, Zhekun, Zhang, Xiuping, Zhang, Yong

Volltext